News | Radiation Therapy | January 22, 2018

ASTRO and ASCO Launch New Cancer Care Quality Registry

Quality Oncology Practice Initiative (QOPI) Reporting Registry designed to track and improve the quality of cancer care delivered in the U.S.

ASTRO and ASCO Launch New Cancer Care Quality Registry

January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment launched this month as part of a collaboration between the American Society of Clinical Oncology (ASCO) and the American Society for Radiation Oncology (ASTRO). In addition to improving the quality of care for people living with cancer, the Quality Oncology Practice Initiative (QOPI) Reporting Registry also makes it easier for medical and radiation oncologists to report quality-related performance metrics required by the federal government.

The registry, a Qualified Clinical Data Registry (QCDR), is the latest joint initiative from ASCO and ASTRO. This platform builds on the Societies' joint efforts over the past several years to improve cancer care by developing measures to track physician performance.

"Our two societies are most interested in promoting the highest quality standards when it comes to patient care, and we have jointly made quality performance, including quality improvement and quality reporting, a shared priority," said ASCO President Bruce E. Johnson, M.D., FASCO. "By launching this registry, we are not only providing tools for improving cancer care for our patients, but are also facilitating our members' responsibility to report their quality performance to the federal government."

"By giving clinics the power to track, refine and improve their performance over time, this inventive tool advances the culture of quality and safety in cancer care," said ASTRO Chair Brian Kavanagh, M.D., MPH, FASTRO. "Additionally, reducing administrative burden affords physicians more time to focus on providing the highest quality care. Through this collaborative effort, ASTRO and ASCO demonstrate our commitment to patient engagement and finding ways to help physicians spend more time interacting with their patients."

Currently, the 2018 QOPI Reporting Registry includes a set of 25 measures to assess the quality of care delivered to cancer patients. Measures address topics such as pain management and the use of diagnostic screening. ASCO and ASTRO are also working together to identify and develop additional quality measures to expand the registry.

This effort builds on the original QOPI, a voluntary self-assessment and improvement program launched by ASCO in 2006 to help hematology-oncology and medical oncology practices assess the quality of the care they provide to patients.

ASCO and ASTRO also co-sponsor five scientific symposia a year together to disseminate the latest advances in cancer care. In addition, ASTRO serves on the Oncology Leadership Council for CancerLinQ, ASCO's health information technology platform to enhance and improve the understanding and treatment of cancer.

For more information: www.instituteforquality.org/qopi-qcp

 

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more